168 related articles for article (PubMed ID: 34641328)
1. Co-Treatments of Edible Curcumin from Turmeric Rhizomes and Chemotherapeutic Drugs on Cytotoxicity and FLT3 Protein Expression in Leukemic Stem Cells.
Chueahongthong F; Tima S; Chiampanichayakul S; Berkland C; Anuchapreeda S
Molecules; 2021 Sep; 26(19):. PubMed ID: 34641328
[TBL] [Abstract][Full Text] [Related]
2. FLT3-specific curcumin micelles enhance activity of curcumin on FLT3-ITD overexpressing MV4-11 leukemic cells.
Tima S; Okonogi S; Ampasavate C; Berkland C; Anuchapreeda S
Drug Dev Ind Pharm; 2019 Mar; 45(3):498-505. PubMed ID: 30572745
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of turmeric curcuminoids on FLT3 expression and cell cycle arrest in the FLT3-overexpressing EoL-1 leukemic cell line.
Tima S; Ichikawa H; Ampasavate C; Okonogi S; Anuchapreeda S
J Nat Prod; 2014 Apr; 77(4):948-54. PubMed ID: 24689857
[TBL] [Abstract][Full Text] [Related]
4. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy.
Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O
Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729
[TBL] [Abstract][Full Text] [Related]
5. Enhanced anticancer potency of doxorubicin in combination with curcumin in gastric adenocarcinoma.
Firouzi Amoodizaj F; Baghaeifar S; Taheri E; Farhoudi Sefidan Jadid M; Safi M; Seyyed Sani N; Hajazimian S; Isazadeh A; Shanehbandi D
J Biochem Mol Toxicol; 2020 Jun; 34(6):e22486. PubMed ID: 32128952
[TBL] [Abstract][Full Text] [Related]
6. Synergism of Curcumin and Cytarabine in the Down Regulation of Multi-Drug Resistance Genes in Acute Myeloid Leukemia.
Shah K; Mirza S; Desai U; Jain N; Rawal R
Anticancer Agents Med Chem; 2016; 16(1):128-35. PubMed ID: 26278546
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
8. FLT3-ITD cooperates with Rac1 to modulate the sensitivity of leukemic cells to chemotherapeutic agents via regulation of DNA repair pathways.
Wu M; Li L; Hamaker M; Small D; Duffield AS
Haematologica; 2019 Dec; 104(12):2418-2428. PubMed ID: 30975911
[TBL] [Abstract][Full Text] [Related]
9. Development and Characterization of FLT3-Specific Curcumin-Loaded Polymeric Micelles as a Drug Delivery System for Treating FLT3-Overexpressing Leukemic Cells.
Tima S; Okonogi S; Ampasavate C; Pickens C; Berkland C; Anuchapreeda S
J Pharm Sci; 2016 Dec; 105(12):3645-3657. PubMed ID: 27751588
[TBL] [Abstract][Full Text] [Related]
10. Synthetic lethality of combined AT-101 with idarubicin in acute myeloid leukemia via blockade of DNA repair and activation of intrinsic apoptotic pathway.
Yang Q; Chen K; Zhang L; Feng L; Fu G; Jiang S; Bi S; Lin C; Zhou Y; Zhao H; Chen XL; Fu G; Xu B
Cancer Lett; 2019 Oct; 461():31-43. PubMed ID: 31301319
[TBL] [Abstract][Full Text] [Related]
11. Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in
Jiang X; Mak PY; Mu H; Tao W; Mak DH; Kornblau S; Zhang Q; Ruvolo P; Burks JK; Zhang W; McQueen T; Pan R; Zhou H; Konopleva M; Cortes J; Liu Q; Andreeff M; Carter BZ
Clin Cancer Res; 2018 May; 24(10):2417-2429. PubMed ID: 29463558
[No Abstract] [Full Text] [Related]
12. Nanomicelles loaded with doxorubicin and curcumin for alleviating multidrug resistance in lung cancer.
Gu Y; Li J; Li Y; Song L; Li D; Peng L; Wan Y; Hua S
Int J Nanomedicine; 2016; 11():5757-5770. PubMed ID: 27843316
[TBL] [Abstract][Full Text] [Related]
13. Phosphoproteome analyses reveal specific implications of Hcls1, p21-activated kinase 1 and Ezrin in proliferation of a myeloid progenitor cell line downstream of wild-type and ITD mutant Fms-like tyrosine kinase 3 receptors.
Habif G; Grasset MF; Kieffer-Jaquinod S; Kuhn L; Mouchiroud G; Gobert-Gosse S
J Proteomics; 2013 Jan; 78():231-44. PubMed ID: 23017497
[TBL] [Abstract][Full Text] [Related]
14. Zwitterionic Polymer Micelles with Dual Conjugation of Doxorubicin and Curcumin: Synergistically Enhanced Efficacy against Multidrug-Resistant Tumor Cells.
Zhao G; Sun Y; Dong X
Langmuir; 2020 Mar; 36(9):2383-2395. PubMed ID: 32036662
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a Novel FLT3 BiTE Molecule for the Treatment of Acute Myeloid Leukemia.
Brauchle B; Goldstein RL; Karbowski CM; Henn A; Li CM; Bücklein VL; Krupka C; Boyle MC; Koppikar P; Haubner S; Wahl J; Dahlhoff C; Raum T; Rardin MJ; Sastri C; Rock DA; von Bergwelt-Baildon M; Frank B; Metzeler KH; Case R; Friedrich M; Balazs M; Spiekermann K; Coxon A; Subklewe M; Arvedson T
Mol Cancer Ther; 2020 Sep; 19(9):1875-1888. PubMed ID: 32518207
[TBL] [Abstract][Full Text] [Related]
16. Curcumin Enhanced Busulfan-Induced Apoptosis through Downregulating the Expression of Survivin in Leukemia Stem-Like KG1a Cells.
Weng G; Zeng Y; Huang J; Fan J; Guo K
Biomed Res Int; 2015; 2015():630397. PubMed ID: 26557682
[TBL] [Abstract][Full Text] [Related]
17. The antitumor compound triazoloacridinone C-1305 inhibits FLT3 kinase activity and potentiates apoptosis in mutant FLT3-ITD leukemia cells.
Augustin E; Skwarska A; Weryszko A; Pelikant I; Sankowska E; Borowa-Mazgaj B
Acta Pharmacol Sin; 2015 Mar; 36(3):385-99. PubMed ID: 25640477
[TBL] [Abstract][Full Text] [Related]
18. Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia.
Alachkar H; Santhanam R; Harb JG; Lucas DM; Oaks JJ; Hickey CJ; Pan L; Kinghorn AD; Caligiuri MA; Perrotti D; Byrd JC; Garzon R; Grever MR; Marcucci G
J Hematol Oncol; 2013 Mar; 6():21. PubMed ID: 23497456
[TBL] [Abstract][Full Text] [Related]
19. The sorafenib plus nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of FLT3 and p53 status.
Zauli G; Celeghini C; Melloni E; Voltan R; Ongari M; Tiribelli M; di Iasio MG; Lanza F; Secchiero P
Haematologica; 2012 Nov; 97(11):1722-30. PubMed ID: 22689683
[TBL] [Abstract][Full Text] [Related]
20. Effect of pure curcumin, demethoxycurcumin, and bisdemethoxycurcumin on WT1 gene expression in leukemic cell lines.
Anuchapreeda S; Tima S; Duangrat C; Limtrakul P
Cancer Chemother Pharmacol; 2008 Sep; 62(4):585-94. PubMed ID: 18034345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]